Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

New Neural Drug Targets: An Evaluation of the Effects of Aprepitant on the Response to Oxycodone

NCT00999544 is registered in ClinicalTrials.gov with Sharon Walsh as lead sponsor.

NCT NCT00999544
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00999544 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
New Neural Drug Targets: An Evaluation of the Effects of Aprepitant on the Response to Oxycodone
Lead sponsor
Sharon Walsh
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2009
Completion date
April 30, 2011
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

narcotic abuse